Nova Eye USA Sales Growth Opportunity
USA Sales Growth Opportunity, iTrack" Advance
TM
•
Nova Eye's direct-to-surgeon sales channel is driving growth of iTrack™
•
A
Active Accounts,
Glaucoma (x200)
B
Inactive Accounts,
Glaucoma (x300)
Advance, Nova Eye's flagship product.
Recruitment of additional sales representatives drives new account
acquisition through improved geographical coverage
Additional marketing and clinical support drives surgeon re-order rates and
enhances product introduction
A
B
Active Accounts, Glaucoma | approx. 200 accounts
Successfully transitioned existing iTrack™ customer accounts
TM
to iTrack Advance during May-June 2023.
Inactive Accounts, Glaucoma | approx. 300 accounts
Reactivation of inactive customer accounts commenced in July 2023
is continuing through FY24.
ΤΜ
iTrack™
ADVANCE
(market opportunity)
C
New Accounts, Glaucoma
D
1)
2)
Potentially 1200(1) accounts available for sales growth via new glaucoma
surgeon accounts
New Accounts, Cataract and Comprehensive
Potentially 9000 (2) accounts available for sales growth via new cataract and
comprehensive surgeon accounts
2,364 glaucoma specialists per Marketscope 2023 Glaucoma Surgical Device Market Report. An account can have more than one
glaucoma surgeon. Management estimates that this equates to between 900 and 2000 accounts. An estimate of 1200 has been made
based on a ratio of two per account
11,238 cataract surgeons per Marketscope 2023 Glaucoma Surgical Device Market Report. An account can have more than one cataract
surgeon. Management estimates that this equates to between 6000 and 11000 accounts. An estimate of 9000 has been made.
D
New Accounts, Cataract and
Comprehensive (x9000)
C
New Accounts,
Glaucoma (x1200)
nova-eye.com | 12View entire presentation